Celebrating Pride Month – A BOPA E&T Webinar with Live Through This, a LGBTIQ+ cancer charity [REGISTER NOW]

BOPA is delighted to have teamed up with Live Through This to celebrate Pride Month.

 

Wednesday 7th June 2023 at 12:00 – 13:00 BST – Click HERE to register

 

To mark Pride Month we are excited to welcome Live Through This to deliver a session on providing LGBTIQ+ Inclusive Care!

This live interactive session will cover:

  • Understanding sexual orientation and gender identity
  • Pronouns and how to use them
  • National data and key research
  • LGBTIQ+ healthcare experiences
  • How the LGBTIQ+ cancer patient experience can differ
  • Impact of LGBTIQ+ identity on cancer risk and treatment
  • How to create inclusive environments

Live Through This is the UK’s only LGBTIQ+ cancer charity proudly led by and for LGBTIQ+ people affected by cancer. To find out more, please visit: https://livethroughthis.co.uk/

 

The session will be delivered by: Stewart O’Callaghan (they/them) & Lee Dibben (they/them), Live Through This

 

Click here for more information on the session.

 

This webinar is FREE for all BOPA members and associates.

Click here to join BOPA

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article